Breast - Female, Phase II
I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Adriana Matutino Kahn, MD
- Alice Wnuk
- Andrea Brennan
- Andrea Silber, MD
- Daniel O'Neil, MD, MPH
- David Witt, MD
- Elizabeth Berger, MD, MS, FACS
- Eric Winer, MD
- Gineesha Abraham
- Gregory Zanieski, MD, FACS
- John Lewin, MD
- Justin Persico, MD
- Kathleen Fenn, MD
- Kathryn Mason
- Lajos Pusztai, MD, DPhil
- Liva Andrejeva-Wright, MD
- Maryam Lustberg, MD, MPH
- Mehra Golshan, MD, MBA
- Melissa Durand, MD
- Michael Cohenuram, MD
- Michael DiGiovanna, MD, PhD
- Michelle Corso
- Neal Fischbach, MD
- Renee Moye
- Sarah Elizabeth Schellhorn, MD
- Tara Sanft, MD
- Tristen Park, MD
- Vanna Dest
- Last Updated04/19/2024
- Study HIC#2000020575